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Abstract 
Mitochondrial function is closely linked to the maintenance of mitochondrial integrity. During short-term anoxia, ion-transport systems 
in the inner membrane are inhibited to protect against loss of the promotive force and associated osmotic imbalance that can cause 
irreversible loss of mitochondrial integrity and function. In two models of chemically induced mitochondrial failure, a prostaglandin B i 
derivative, di-calciphor, protected against mitochondrial failure and prevented cell death. Characteristics were similar to those observed in 
mitochondria during short-term anoxia. Thus, the results indicate that di-calciphor may represent a new type of mitochondrial protectant 
that inhibits ion transport and thus slows the loss of osmotic stability and delays mitochondrial dysfunction under traumatic and 
toxicologic onditions. 
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1. Introduction 
Since the general acceptance of chemiosmotic oupling 
as the central mechanism of oxidative phosphorylation 
about 20 years ago [ 1,2], investigations have shifted from a 
primary focus on mitochondrial function to a focus on 
mitochondrial dysfunction. The present report provides a 
summary of our studies which address the interface of 
function and dysfunction, namely, conditions in which 
oxygen deficiency shifts mitochondrial function to dys- 
function. 
Oxygen deficiency is commonly associated with many 
pathologic processes. As a result, the consequences of 
impaired mitochondrial function and the mechanisms of 
mitochondrial protection during oxygen deficiency are of 
great importance both to the understanding of cellular 
homeostasis and to developing improved means to protect 
against mitochondrial failure. This is most relevant to 
individuals with mitochondrial genetic defects or genomic 
deletions associated with aging because they have compro- 
mised mitochondria that are more susceptible to failure. 
The current presentation provides a summary of studies 
which show that oxygen deficiency substantially increases 
cellular susceptibility to oxidative injury and describes 
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mechanisms that exist in mammalian cells to protect against 
mitochondrial failure during short-term anoxia. 
2. Results and discussion 
2.1. Oxygen deficiency increases susceptibiliO' to acute 
cell inju~ .from oxidants 
In pioneering studies more than a decade ago, Granger 
and associates [3] showed that antioxidants could protect 
against tissue injury during post-ischemic reoxygenation. 
In the intervening period, it has become apparent that 
reactive oxygen species are commonly generated uring 
this period and can result in cell injury [4]. In addition, 
several studies have indicated that the mitochondria re a 
primary target of oxidative injury. For instance, in rat 
hepatocytes, treatment with 3-hydroxy-4-pentenoate results 
in selective depletion of mitochondrial glutathione [5] and 
greatly potentiates toxicity due to t-butylhydroperoxide 
(Fig. 1). Thus, we addressed whether conditions that limit 
mitochondrial function, namely, states of oxygen defi- 
ciency, affect the susceptibility of cells to oxidative injury. 
We have examined this question with three different 
experimental models. In the first, we addressed whether 
cells exposed acutely to oxygen deficiency were more 
vulnerable to oxidative injury than normoxic cells [6]. The 
results showed that substantially more cell killing occurred 
in hepatocytes incubated under steady-state hypoxic condi- 
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Fig. 1. Effect of depleting mitochondrial GSH on the susceptibility to 
oxidative injury. Rat hepatocytes were incubated with 3-hydroxy-4- 
pentenoate to selectively deplete mitochondrial GSH and then treated 
with a concentration of t-butylhydroperoxide (0.3 mM) that did not kill 
control cells. Measurements of Trypan blue exclusion showed that the 
oxidant did not kill the control cells (©) but killed the cells in which 
mitochondrial GSH was depleted (0) .  3-Hydroxy-4-pentenoate lone 
was not toxic and selective depletion of cytoplasmic GSH did not 
potentiate toxicity (data from [5]). 
tions (Fig. 2). Studies of the mechanistic basis of this 
effect showed that NADPH supply for reduction of perox- 
ides by the GSH-dependent pathways was limited [7], as 
was the rate of GSH synthesis [8]. 
In a second model, we examined whether hepatocytes 
previously exposed to anoxia were more vulnerable to 
oxidative injury than cells that had not been exposed to 
anoxia [9]. The results showed that a prior exposure to 
30-60 min of anoxia dramatically increased the sensitivity 
of cells to a constant oxidative challenge (Fig. 2). This 
finding is particularly important because it demonstrates 
that even without an enhanced generation of oxidants 
during post-ischemic reoxygenation, cells are more vulner- 
able to oxidative injury. Thus, conditions which could be 
tolerated under normoxia can become pathologic following 
transient interruption of blood flow. 
We studied the effects of chronic in vivo oxygen defi- 
ciency on sensitivity to oxidative injury in a third model 
with rat hepatocytes [ 10]. Rats were maintained for 8 to 10 
days under conditions of normoxia or a moderately severe 
hypoxia (10.5% 02 under normobaric onditions), hepato- 
cytes were isolated, and experiments were performed in 
vitro. Cells from animals that were previously hypoxic 
were comparable in viability and several other character- 
istics but were considerably more sensitive to toxicity 
induced by t-butylhydroperoxide (Fig. 2). Thus, with three 
different models of oxygen deficiency, cells are more 
susceptible to injury from oxidants. 
Because mitochondria re a sensitive target of injury 
due to oxidants and are functionally impaired by oxygen 
deficiency, these results uggest that hypoxic episodes may 
be particularly important contributors to mitochondrial 
dysfunction. Mitochondrial genomic damage associated 
with age-related diseases in humans is thought o occur by 
oxidative mechanisms [11]. Our results show that impaired 
circulatory and respiratory supply of 0 2 to tissue may 
substantially exacerbate the oxidative damage and there- 
fore be an important contributing factor to age-related 
disease. 
2.2. Protection against mitochondrial dysfunction during 
short-term anoxia 
The period of time that mammalian cells can tolerate 
anoxia is highly variable [12], depending upon cell type 
and conditions such as functional load and nutritional 
status. Of particular interest, cell death is substantially 
delayed from the time required for redox changes in the 
mitochondrial electron transport chain and bioenergetic 
changes as reflected in the cellular ATP pool (Fig. 3). 
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Fig. 2. Oxygen deficiency increases the susceptibility of cells to oxidative injury. In panel A, rat hepatocytes were incubated under a physiological oxygen 
concentration (20/zM; triangles) or anoxic conditions (closed circles) with 0.6 mM t-butylhydroperoxide. The results howed that anoxic cells were more 
susceptible to injury as measured by trypan blue exclusion. Untreated anoxic cells were not killed under these conditions (open circles). Data from [6]. In 
panel B, cells were incubated for 1 h under aerobic (open symbols) or anaerobic (closed symbols) conditions and then reoxygenated. Following treatment 
with 0.3 mM t-butylhydroperoxide (circles), extensive cell death occurred in the cells that were previously anoxic while little toxicity was observed in the 
cells that were continuously aerobic (triangles). Data from [9]. In panel C, toxicity of 0.3 mM t-butylhydroperoxide (circles) in cells from normoxic rats 
(open symbols) was compared to that in cells from animals that had been maintained for 8-10 days in an environment with 10.5% oxygen (closed 
symbols). The results how that in vivo hypoxia increases the sensitivity of cells to oxidative injury. Data from [10]. 
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Several mechanisms exist in cells to protect against cell 
death during anoxia, such as enhanced ATP production by 
glycolysis, inhibition of phospholipases by low pH, and 
inhibition of ion transporters and channels in the plasma 
membrane. Our research has provided evidence for an 
additional mechanism that functions during short-term 
anoxia to protect against mitochondrial swelling and lysis 
[13-15]. This mechanism allows preservation of the struc- 
tural and functional integrity of mitochondria in the ab- 
sence of energy supply from electron transport and extends 
the time of O 2 deficiency that can be tolerated without 
irreversible injury. 
The proposed mechanism is based upon data acquired 
from analyses of rat hepatocytes under anoxic conditions 
and interpreted in terms of a coordinated multisite regula- 
tion model [16] for oxidative phosphorylation (Fig. 4). In 
this model, 5 principal control sites are recognized. These 
include the control of flow of electrons into the mitochon- 
drial chain that is regulated by NAD+-linked dehydro- 
genases and the flow of electrons to O 2 at cytochrome 
oxidase. Coordinated regulation at these two sites provides 
control over the energy available for mitochondrial func- 
tions dependent upon the mitochondrial membrane poten- 
tial (A~0) and pH gradient (ApH). Utilization of A~O and 
ApH for ATP supply to the cytoplasm occurs by three 
systems, the phosphate transporter (H 2PO/ /OH antiport 
system), the ATP synthase and the adenine nucleotide 
transporter (ANT). Regulation at these sites allows control 
of energy utilization for ATP synthesis independently of
other mitochondrial energy utilization, such as for Ca 2+ 
cycling [17]. Coordinated regulation is necessary because 
phosphate uptake in the absence of ATP synthesis or 
export would rapidly result in mitochondrial swelling and 
lysis. During anoxia, this type of regulation allows for 
inhibition of utilization of A~0 and ApH for ATP produc- 
tion. This preserves both A~ and ApH so that osmotic 
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Fig. 3. Time-course of effects of anoxia on pyridine nucleotide redox 
state (O), ATP (C)) and cell viability (z~) in rat hepatocytes. Data from 
[19] and [24]. 
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Fig. 4. Coordinated multisite control model for mitochondrial function. 
Generation of the proton-motive force (Ap) is controlled by coordinate 
regulation of electron flow into the mitochondrial e ectron transport chain 
at the NAD+-linked dehydrogenases and out of the chain at cytochrome 
oxidase. Utilization of Ap for ATP supply to the cytoplasm is controlled 
by coordinate regulation of the ATP synthase, adenine nucleotide translo- 
cator (ANT) and the phosphate transporter (PIT). This allows ATP supply 
to the cytoplasm to be relatively independent of the other uses of Ap in 
the mitochondria. This coordinated multisite regulation also provides a 
mechanism to preserve osmotic balance and prevent swelling in the 
mitochondria under anoxic conditions because simultaneous inhibition of 
the ATP synthase, ANT and phosphate transporter substantially decreases 
the rate of dissipation of 3p. 
stability can be maintained for an extended time even 
though cytoplasmic ATP drops precipitously [13]. 
2.3. Effect of KCN on mitochondrial function and cell 
viabili O, 
Isolated mitochondria exposed to anoxia have a very 
weak protective response, suggesting that the mechanisms 
protecting against mitochondrial failure may involve a 
diffusible species. Such a species could be generated by 
subunits of cytochrome oxidase that have unknown func- 
tions [18]. Indeed, cytochrome oxidase would provide an 
ideal sensor for oxygen deficiency because it normally 
exists with cytochrome a3 in the ferric form which be- 
comes reduced to the ferrous form during hypoxia. A shift 
in redox state (from < I% to > 99% ferrous) with an 
associated conformational change could provide a very 
sensitive means to signal O 2 deficiency. 
To test whether inhibition of mitochondrial function 
under conditions where cytochrome a 3 was trapped in the 
ferric form would interfere with mitochondrial protection. 
we examined the effects of KCN on mitochondrial func- 
tions and cell viability [19]. The results showed that cy- 
tosolic ATP fell with the same kinetics as seen for anoxia 
(Fig. 5). In contrast, control of mitochondrial ion transport 
and osmotic regulation was lost in the presence of cyanide, 
and cyanide-treated cells died much more rapidly than did 
anoxic cells ([19]; Fig. 5). Thus, in the presence of KCN, 
mitochondria fail and cells die much more rapidly than 
they do when they are exposed to anoxia. 
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Fig. 5. Comparison of the effects of KCN and anoxia on ATP depletion 
(left panel) and viability (right panel) in hepatocytes. Time-course of
effects of 0.5 mM KCN (O) and anoxia (O) on ATP was measured by 
HPLC and effects on viability were measured by Trypan blue exclusion. 
Data from [19]. 
2.4. Protection against mitochondrial .failure by di-calci- 
phor 
Using this model for mitochondrial failure induced by 
KCN, we examined the effects of a prostaglandin deriva- 
tive (di-calciphor) that had previously been reported to 
protect mitochondria [20]. Addition of di-calciphor to 
KCN-treated hepatocytes did not alter the kinetics or ex- 
tent of ATP loss but protected against cell death ([21]; Fig. 
6). Di-calciphor protected against mitochondrial loss of 
A~b, loss of ApH, loading of phosphate and swelling (Fig. 
6). Thus, the results indicate that di-calciphor may protect 
against cell death by protecting against mitochondrial fail- 
ure. The characteristics of protection by di-calciphor ap- 
pear to be identical to the endogenous mechanisms that 
protect during short-term anoxia, indicating that a more 
detailed understanding of this mechanism ay provide the 
basis for developing therapeutic means to protect against 
mitochondrial dysfunction and disease. 
However, because KCN is a relatively non-specific 
poison and can affect systems other than mitochondria, we 
felt that it was necessary to determine whether di-calciphor 
could protect against mitochondrial failure induced by a 
very specific mitochondrial poison. Consequently, we ex- 
amined the effects of di-calciphor on cell death induced by 
antimycin A [22]. As found with KCN-treated hepatocytes, 
di-calciphor protected against cell death but did not alter 
the loss of ATP. Mitochondrial A~b and ApH were pre- 
served by di-calciphor, and phosphate uptake and swelling 
were prevented. Thus, di-calciphor appears to protect cells 
specifically by preventing mitochondrial failure. 
In ongoing studies, we have recognized that di-calci- 
phor exists as multiple positional and stereoisomers, only 
some of which are functional in providing protection 
against mitochondrial failure [23]. Because of this hetero- 
geneity, future studies will be needed to establish the 
precise stereochemistry of the active isomers as a prelude 
to defining the specific biomolecules through which di- 
calciphor exerts its remarkable biologic activity. 
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Fig. 6. Effects of di-calciphor on the KCN-induced changes in hepatocyte viability, ATP loss, pH gradient, mitochondrial membrane potential, 
mitochondrial phosphate content (nmol/106 cells) and mitochondrial volume (pA/106 cells): (O) cells with 0.5 mM KCN; (O) cells with 0.5 mM KCN 
and 10 /~M di-calciphor; and (A) cells with di-calciphor alone. Other panels were from studies done at 30 rain with l0 /~M di-calciphor and 0.5 mM 
KCN. Data from [21]. 
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3. Summary 
In summary, our studies have shown that mitochondria 
contain an endogenous protective mechanism that protects 
against mitochondrial failure during short-term anoxia. The 
prostaglandin B~ derivative, di-calciphor, appears to acti- 
vate this protective mechanism and delay irreversible 
swelling and lysis by inhibiting ATP synthase and other 
kinetically active ion transport systems. The mechanism 
thus preserves mitochondrial integrity and allows recovery 
of mitochondrial function even following extensive decline 
in cellular energetics as reflected in the cytoplasmic ATP 
pool. 
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